Experimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer's disease

Journal of Nutritional Biochemistry

Volumn 20, Issue 1, 2009, Pages 1-10

  Boudrault, Cynthia ^a   Bazinet, Richard P ^a   Ma, David W L ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

Alzheimer's Disease; DHA; Fish oil; Mouse models; n 3 PUFA

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID ETHYL ESTER; OMEGA 3 FATTY ACID;

ALZHEIMER DISEASE; CAVEOLA; CELL CULTURE; CLINICAL TRIAL; DIETARY INTAKE; DRUG EFFECT; DRUG MECHANISM; EXPERIMENTAL MODEL; FOOD INTAKE; GENE EXPRESSION; HUMAN; LIPID RAFT; NEUROPROTECTION; NONHUMAN; REVIEW; TREATMENT OUTCOME;

AGING; ALZHEIMER DISEASE; ANIMALS; BRAIN; CELLS, CULTURED; DIET; DISEASE MODELS, ANIMAL; FATTY ACIDS, OMEGA-3; FISH OILS; HUMANS; MEMBRANE MICRODOMAINS; MICE; RATS; RISK;

EID: 57049137646     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2008.05.016     Document Type: Review

References (75)

1. The Canadian Study of Health and Aging Working Group. The incidence of dementia in Canada. Neurology 55 (2000) 66-73
2. Alzheimer's Association Alzheimer's disease facts and figures 2007.
3. Hebert L.E., Scherr P.A., Bienias J.L., Bennett D.A., and Evans D.A. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 60 (2003) 1119-1122
4. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 430 (2004) 631-639
5. Brunkan A.L., and Goate A.M. Presenilin function and gamma-secretase activity. J Neurochem 93 (2005) 769-792
6. Morris M.C. Diet and Alzheimer's disease: what the evidence shows. Med Gen Med 6 (2004) 48
7. Marszalek J.R., and Lodish H.F. Docosahexaenoic acid, fatty acid-interacting proteins, and neuronal function: breastmilk and fish are good for you. Annu Rev Cell Dev Biol 21 (2005) 633-657
8. Haag M. Essential fatty acids and the brain. Can J Psychiatry 48 (2003) 195-203
9. Pawlosky R.J., Hibbeln J.R., Novotny J.A., and Salem Jr. N. Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. J Lipid Res 42 (2001) 1257-1265
10. Whelan J., and Rust C. Innovative dietary sources of n-3 fatty acids. Annu Rev Nutr 26 (2006) 75-103
11. Muskiet F.A., van Goor S.A., Kuipers R.S., Velzing-Aarts F.V., Smit E.N., Bouwstra H., et al. Long-chain polyunsaturated fatty acids in maternal and infant nutrition. Prostaglandins Leukot Essent Fatty Acids 75 (2006) 135-144
12. Salem Jr. N., Litman B., Kim H.Y., and Gawrisch K. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 36 (2001) 945-959
13. Innis S.M. Dietary (n-3) fatty acids and brain development. J Nutr 137 (2007) 855-859
14. Suzuki H., Park S.J., Tamura M., and Ando S. Effect of the long-term feeding of dietary lipids on the learning ability, fatty acid composition of brain stem phospholipids and synaptic membrane fluidity in adult mice: a comparison of sardine oil diet with palm oil diet. Mech Ageing Dev 101 (1998) 119-128
15. Favreliere S., Stadelmann-Ingrand S., Huguet F., De J.D., Piriou A., Tallineau C., et al. Age-related changes in ethanolamine glycerophospholipid fatty acid levels in rat frontal cortex and hippocampus. Neurobiol Aging 21 (2000) 653-660
16. Chen C.T., Ma D.W., Kim J.H., Mount H.T., and Bazinet R.P. The low density lipoprotein receptor is not necessary for maintaining mouse brain polyunsaturated fatty acid concentrations. J Lipid Res 49 (2008) 147-152
17. Igarashi M., Demar Jr. J.C., Ma K., Chang L., Bell J.M., and Rapoport S.I. Docosahexaenoic acid synthesis from alpha-linolenic acid by rat brain is unaffected by dietary n-3 PUFA deprivation. J Lipid Res 48 (2007) 1150-1158
18. Bernoud N., Fenart L., Benistant C., Pageaux J.F., Dehouck M.P., Moliere P., et al. Astrocytes are mainly responsible for the polyunsaturated fatty acid enrichment in blood-brain barrier endothelial cells in vitro. J Lipid Res 39 (1998) 1816-1824
19. Reger M.A., Henderson S.T., Hale C., Cholerton B., Baker L.D., Watson G.S., et al. Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol Aging 25 (2004) 311-314
20. Freemantle E., Vandal M., Tremblay-Mercier J., Tremblay S., Blachere J.C., Begin M.E., et al. Omega-3 fatty acids, energy substrates, and brain function during aging. Prostaglandins Leukot Essent Fatty Acids 75 (2006) 213-220
21. Joardar A., and Das S. Effect of Fatty acids isolated from edible oils like mustard, linseed or coconut on astrocytes maturation. Cell Mol Neurobiol 27 (2007) 973-983
22. Joardar A., Sen A.K., and Das S. Docosahexaenoic acid facilitates cell maturation and beta-adrenergic transmission in astrocytes. J Lipid Res 47 (2006) 571-581
23. Lynch A.M., Loane D.J., Minogue A.M., Clarke R.M., Kilroy D., Nally R.E., et al. Eicosapentaenoic acid confers neuroprotection in the amyloid-beta challenged aged hippocampus. Neurobiol Aging 28 (2007) 845-855
24. Salvati S., Natali F., Attorri L., Di B.R., Leonardi F., Di B.A., et al. Eicosapentaenoic acid stimulates the expression of myelin proteins in rat brain. J Neurosci Res 86 (2008) 776-784
25. Barberger-Gateau P., Letenneur L., Deschamps V., Peres K., Dartigues J.F., and Renaud S. Fish, meat, and risk of dementia: cohort study. BMJ 325 (2002) 932-933
26. Beydoun M.A., Kaufman J.S., Satia J.A., Rosamond W., and Folsom A.R. Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study. Am J Clin Nutr 85 (2007) 1103-1111
27. Engelhart M.J., Geerlings M.I., Ruitenberg A., Van Swieten J.C., Hofman A., Witteman J.C., et al. Diet and risk of dementia: does fat matter?: the Rotterdam Study. Neurology 59 (2002) 1915-1921
28. Huang T.L., Zandi P.P., Tucker K.L., Fitzpatrick A.L., Kuller L.H., Fried L.P., et al. Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4. Neurology 65 (2005) 1409-1414
29. Kalmijn S., Launer L.J., Ott A., Witteman J.C., Hofman A., and Breteler M.M. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol 42 (1997) 776-782
30. Laurin D., Verreault R., Lindsay J., Dewailly E., and Holub B.J. Omega-3 fatty acids and risk of cognitive impairment and dementia. J Alzheimers Dis 5 (2003) 315-322
31. Morris M.C., Evans D.A., Bienias J.L., Tangney C.C., Bennett D.A., Wilson R.S., et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 60 (2003) 940-946
32. Schaefer E.J., Bongard V., Beiser A.S., Lamon-Fava S., Robins S.J., Au R., et al. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol 63 (2006) 1545-1550
33. van Gelder B.M., Tijhuis M., Kalmijn S., and Kromhout D. Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study. Am J Clin Nutr 85 (2007) 1142-1147
34. Conquer J.A., Tierney M.C., Zecevic J., Bettger W.J., and Fisher R.H. Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids 35 (2000) 1305-1312
35. Otsuka M., Yamaguchi K., and Ueki A. Similarities and differences between Alzheimer's disease and vascular dementia from the viewpoint of nutrition. Ann N Y Acad Sci 977 (2002) 155-161
36. Tully A.M., Roche H.M., Doyle R., Fallon C., Bruce I., Lawlor B., et al. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study. Br J Nutr 89 (2003) 483-489
37. Freund-Levi Y., Eriksdotter-Jonhagen M., Cederholm T., Basun H., Faxen-Irving G., Garlind A., et al. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol 63 (2006) 1402-1408
38. Boston P.F., Bennett A., Horrobin D.F., and Bennett C.N. Ethyl-EPA in Alzheimer's disease - a pilot study. Prostaglandins Leukot Essent Fatty Acids 71 (2004) 341-346
39. Kotani S., Sakaguchi E., Warashina S., Matsukawa N., Ishikura Y., Kiso Y., et al. Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neurosci Res 56 (2006) 159-164
40. Lukiw W.J., Cui J.G., Marcheselli V.L., Bodker M., Botkjaer A., Gotlinger K., et al. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest 115 (2005) 2774-2783
41. Corrigan F.M., Horrobin D.F., Skinner E.R., Besson J.A., and Cooper M.B. Abnormal content of n-6 and n-3 long-chain unsaturated fatty acids in the phosphoglycerides and cholesterol esters of parahippocampal cortex from Alzheimer's disease patients and its relationship to acetyl CoA content. Int J Biochem Cell Biol 30 (1998) 197-207
42. Prasad M.R., Lovell M.A., Yatin M., Dhillon H., and Markesbery W.R. Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem Res 23 (1998) 81-88
43. Soderberg M., Edlund C., Kristensson K., and Dallner G. Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids 26 (1991) 421-425
44. Oksman M., Iivonen H., Hogyes E., Amtul Z., Penke B., Leenders I., et al. Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice. Neurobiol Dis 23 (2006) 563-572
45. Akbar M., Calderon F., Wen Z., and Kim H.Y. Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival. Proc Natl Acad Sci U S A 102 (2005) 10858-10863
46. Florent S., Malaplate-Armand C., Youssef I., Kriem B., Koziel V., Escanye M.C., et al. Docosahexaenoic acid prevents neuronal apoptosis induced by soluble amyloid-beta oligomers. J Neurochem 96 (2006) 385-395
47. Lim G.P., Calon F., Morihara T., Yang F., Teter B., Ubeda O., et al. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci 25 (2005) 3032-3040
48. Calon F., Lim G.P., Yang F., Morihara T., Teter B., Ubeda O., et al. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 43 (2004) 633-645
49. Hashimoto M., Hossain S., Agdul H., and Shido O. Docosahexaenoic acid-induced amelioration on impairment of memory learning in amyloid beta-infused rats relates to the decreases of amyloid beta and cholesterol levels in detergent-insoluble membrane fractions. Biochim Biophys Acta 1738 (2005) 91-98
50. Hashimoto M., Tanabe Y., Fujii Y., Kikuta T., Shibata H., and Shido O. Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats. J Nutr 135 (2005) 549-555
51. Hashimoto M., Hossain S., Shimada T., Sugioka K., Yamasaki H., Fujii Y., et al. Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. J Neurochem 81 (2002) 1084-1091
52. Hashimoto M., Hossain S., Shimada T., and Shido O. Docosahexaenoic acid-induced protective effect against impaired learning in amyloid beta-infused rats is associated with increased synaptosomal membrane fluidity. Clin Exp Pharmacol Physiol 33 (2006) 934-939
53. Green K.N., Martinez-Coria H., Khashwji H., Hall E.B., Yurko-Mauro K.A., Ellis L., et al. Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels. J Neurosci 27 (2007) 4385-4395
54. Higgins G.A., and Jacobsen H. Transgenic mouse models of Alzheimer's disease: phenotype and application. Behav Pharmacol 14 (2003) 419-438
55. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39 (2003) 409-421
56. Kris-Etherton P.M., Taylor D.S., Yu-Poth S., Huth P., Moriarty K., Fishell V., et al. Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr 71 (2000) 179S-188S
57. Krauss R.M., Eckel R.H., Howard B., Appel L.J., Daniels S.R., Deckelbaum R.J., et al. AHA Dietary Guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Stroke 31 (2000) 2751-2766
58. Sioen I.A., Pynaert I., Matthys C., De B.G., Van C.J., and De H.S. Dietary intakes and food sources of fatty acids for Belgian women, focused on n-6 and n-3 polyunsaturated fatty acids. Lipids 41 (2006) 415-422
59. Puglielli L., Tanzi R.E., and Kovacs D.M. Alzheimer's disease: the cholesterol connection. Nat Neurosci 6 (2003) 345-351
60. Farooqui, Horrocks, and Farooqui T. Modulation of inflammation in brain: a matter of fat. J Neurochem 101 (2007) 577-599
61. Stephenson D.T., Lemere C.A., Selkoe D.J., and Clemens J.A. Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain. Neurobiol Dis 3 (1996) 51-63
62. Yasojima K., Schwab C., McGeer E.G., and McGeer P.L. Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs. Brain Res 830 (1999) 226-236
63. Bazan N.G. The onset of brain injury and neurodegeneration triggers the synthesis of docosanoid neuroprotective signaling. Cell Mol Neurobiol 26 (2006) 901-913
64. Rao J.S., Ertley R.N., Demar Jr. J.C., Rapoport S.I., Bazinet R.P., and Lee H.J. Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex. Mol Psychiatry 12 (2007) 151-157
65. Rao J.S., Ertley R.N., Lee H.J., DeMar Jr. J.C., Arnold J.T., Rapoport S.I., et al. n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Mol Psychiatry 12 (2007) 36-46
66. Pike L.J. Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function. J Lipid Res 47 (2006) 1597-1598
67. Hnasko R., and Lisanti M.P. The biology of caveolae: lessons from caveolin knockout mice and implications for human disease. Mol Interv 3 (2003) 445-464
68. Ikezu T., Trapp B.D., Song K.S., Schlegel A., Lisanti M.P., and Okamoto T. Caveolae, plasma membrane microdomains for alpha-secretase-mediated processing of the amyloid precursor protein. J Biol Chem 273 (1998) 10485-10495
69. Cordy J.M., Hussain I., Dingwall C., Hooper N.M., and Turner A.J. Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein. Proc Natl Acad Sci U S A 100 (2003) 11735-11740
70. Ehehalt R., Keller P., Haass C., Thiele C., and Simons K. Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J Cell Biol 160 (2003) 113-123
71. Riddell D.R., Christie G., Hussain I., and Dingwall C. Compartmentalization of beta-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts. Curr Biol 11 (2001) 1288-1293
72. Ma D.W., Seo J., Davidson, Callaway E.S., Fan Y.Y., Lupton J.R., et al. n-3 PUFA alter caveolae lipid composition and resident protein localization in mouse colon. FASEB J 18 (2004) 1040-1042
73. Schley P.D., Brindley D.N., and Field C.J. (n-3) PUFA alter raft lipid composition and decrease epidermal growth factor receptor levels in lipid rafts of human breast cancer cells. J Nutr 137 (2007) 548-553
74. Shaikh S.R., Cherezov V., Caffrey M., Stillwell W., and Wassall S.R. Interaction of cholesterol with a docosahexaenoic acid-containing phosphatidylethanolamine: trigger for microdomain/raft formation?. Biochemistry 42 (2003) 12028-12037
75. Cunnane S.C., Plourde M., Vandal M., Freemantle E., Tremblay-Mercier J., and Bégin M. Linking low docosahexaenoic acid intake to Alzheimer's disease: caution recommended. OCL 14 (2007) 1-5